Theravance Biopharma Aktie
Finanztrends
Deine Einschätzung
Theravance Biopharma Aktie
Heute verliert die Theravance Biopharma Aktie an Boden, ein Rückgang von -1,75 %.
Was spricht für und gegen Theravance Biopharma in den nächsten Jahren?
Pro
?
A****************
?
U****************
?
M************
Kontra
?
L*********** I********** f** d** n******* J****
?
W******* i* V********
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Theravance Biopharma im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1,75 % | -1,18 % | 6,33 % | 84,62 % | 7,01 % | 72,31 % | 13,51 % |
| Rockwell Medical Inc. | -0,42 % | 17,14 % | 35,15 % | -54,42 % | 40,95 % | -43,58 % | -92,78 % |
| Pacira Pharmaceuticals | -0,57 % | 4,22 % | -19,91 % | -20,64 % | -19,91 % | -49,42 % | -69,11 % |
| Twist Bioscience Corp | -1,13 % | 2,32 % | 24,58 % | -30,52 % | 28,47 % | 39,36 % | -73,30 % |
Kommentare
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue